[go: up one dir, main page]

PL354257A1 - Sposób otrzymywania powlekanych granul o ukrytym sSposób otrzymywania powlekanych granul o ukrytym smaku, niezwłocznie uwalniających aktywny czynnikmaku, niezwłocznie uwalniających aktywny czynnik - Google Patents

Sposób otrzymywania powlekanych granul o ukrytym sSposób otrzymywania powlekanych granul o ukrytym smaku, niezwłocznie uwalniających aktywny czynnikmaku, niezwłocznie uwalniających aktywny czynnik

Info

Publication number
PL354257A1
PL354257A1 PL00354257A PL35425700A PL354257A1 PL 354257 A1 PL354257 A1 PL 354257A1 PL 00354257 A PL00354257 A PL 00354257A PL 35425700 A PL35425700 A PL 35425700A PL 354257 A1 PL354257 A1 PL 354257A1
Authority
PL
Poland
Prior art keywords
instant release
masked taste
active particle
making granules
agent
Prior art date
Application number
PL00354257A
Other languages
English (en)
Other versions
PL201782B1 (pl
Inventor
NoureddineNouri Noureddine Nouri
Jean-MarcZuccarelli Jean-Marc Zuccarelli
CharlesChauveau Charles Chauveau
EtienneBruna Etienne Bruna
Original Assignee
Ethypharmethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharmethypharm filed Critical Ethypharmethypharm
Publication of PL354257A1 publication Critical patent/PL354257A1/pl
Publication of PL201782B1 publication Critical patent/PL201782B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL354257A 1999-07-08 2000-06-30 Sposób wytwarzania powlekanych granul o zamaskowanym smaku i niezwłocznie uwalniających składnik czynny, powlekana granula, szybko krusząca się wielocząstkowa tabletka oraz szybko rozpadająca się tabletka PL201782B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9909047A FR2795962B1 (fr) 1999-07-08 1999-07-08 Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
PCT/FR2000/001855 WO2001003672A1 (fr) 1999-07-08 2000-06-30 Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif

Publications (2)

Publication Number Publication Date
PL354257A1 true PL354257A1 (pl) 2003-12-29
PL201782B1 PL201782B1 (pl) 2009-05-29

Family

ID=9548029

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354257A PL201782B1 (pl) 1999-07-08 2000-06-30 Sposób wytwarzania powlekanych granul o zamaskowanym smaku i niezwłocznie uwalniających składnik czynny, powlekana granula, szybko krusząca się wielocząstkowa tabletka oraz szybko rozpadająca się tabletka

Country Status (31)

Country Link
US (1) US6660382B2 (pl)
EP (1) EP1194125B1 (pl)
JP (1) JP4749639B2 (pl)
KR (1) KR100767928B1 (pl)
CN (1) CN1220485C (pl)
AT (1) ATE360412T1 (pl)
AU (1) AU760006B2 (pl)
BG (1) BG65615B1 (pl)
BR (1) BR0012250A (pl)
CA (1) CA2375600C (pl)
CY (1) CY1107695T1 (pl)
CZ (1) CZ300154B6 (pl)
DE (1) DE60034565T2 (pl)
DK (1) DK1194125T3 (pl)
DZ (1) DZ3257A1 (pl)
EA (1) EA003161B1 (pl)
ES (1) ES2284507T3 (pl)
FR (1) FR2795962B1 (pl)
HK (1) HK1049119B (pl)
HU (1) HU229568B1 (pl)
IL (2) IL147212A0 (pl)
MA (1) MA25426A1 (pl)
MX (1) MXPA01013354A (pl)
NO (1) NO331256B1 (pl)
NZ (1) NZ516594A (pl)
PL (1) PL201782B1 (pl)
PT (1) PT1194125E (pl)
SK (1) SK287322B6 (pl)
TR (1) TR200200013T2 (pl)
WO (1) WO2001003672A1 (pl)
ZA (1) ZA200200344B (pl)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
WO2002009669A2 (en) * 2000-08-01 2002-02-07 Inhale Therapeutic Systems, Inc. Apparatus and process to produce particles having a narrow size distribution and particles made thereby
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
DE60124895D1 (de) * 2001-07-26 2007-01-11 Ethypharm Sa Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2834212B1 (fr) * 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US20050269722A1 (en) * 2002-07-17 2005-12-08 Stefano De Luigi Brushci Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
AU2003249478A1 (en) * 2002-07-19 2004-02-09 Ranbaxy Laboratories Limited Taste masked sumatriptan tablets and processes for their preparation
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040151771A1 (en) 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
KR20060015587A (ko) 2003-05-08 2006-02-17 넥타 쎄라퓨틱스 유케이 리미티드 미립물
AU2004247076A1 (en) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition comprising triptans and NSAIDs
EP1656117A1 (en) * 2003-08-11 2006-05-17 Merck Frosst Canada Ltd. Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
JP5123517B2 (ja) * 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
JP5405752B2 (ja) * 2007-01-31 2014-02-05 大日本住友製薬株式会社 被覆された薬物含有粒子および該粒子を含む固形製剤
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
KR100895942B1 (ko) * 2007-05-08 2009-05-07 조선대학교산학협력단 생약 추출물을 함유하는 구강 내 속붕해성 제제 조성물 및그의 제조 방법
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
US9724362B2 (en) 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
JPWO2010018614A1 (ja) * 2008-08-11 2012-01-26 味の素株式会社 呈味性が改善された親水性アミノ酸含有製剤
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
KR101069118B1 (ko) 2008-10-22 2011-09-30 경상대학교산학협력단 장용해성 염화콜린의 제조방법 및 이의 방법에 따라 제조되는 염화콜린
CN101879141B (zh) * 2009-05-05 2013-07-17 烟台绿叶动物保健品有限公司 一种掩味替米考星胃溶颗粒制剂
WO2010150221A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Taste masked pharmaceutical compositions of pregabalin
EP2316433A1 (en) * 2009-10-22 2011-05-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of flurbiprofen
CA2777937C (en) * 2009-10-26 2017-08-29 Merck Sharp & Dohme Corp. Solid pharmaceutical compositions containing an integrase inhibitor
BR112012010170A2 (pt) * 2009-10-28 2016-04-12 Mcneil Ppc Inc composições de revestimento para desintegração/dissolução rápida
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
TR200909613A1 (tr) * 2009-12-22 2011-07-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Pregabalinin farmasötik bileşimleri.
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
AU2011274845B2 (en) * 2010-07-09 2015-07-30 Teijin Limited Orally disintegrating tablet
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
KR101481772B1 (ko) 2012-06-19 2015-01-14 주식회사 아리바이오 추출물을 고농도로 함유하는 과립 또는 환의 제조방법
CN102908337B (zh) * 2012-10-12 2014-03-05 大连医诺生物有限公司 微囊化氨基酸组合物及其制备方法
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2015130760A1 (en) 2014-02-25 2015-09-03 Orbis Biosciences, Inc. Taste masking drug formulations
CN106659792B (zh) 2014-05-08 2020-04-28 西梯茜生命工学股份有限公司 含氯丙咪嗪的遮味口服药物制剂
WO2015170939A1 (ko) * 2014-05-08 2015-11-12 주식회사 씨티씨바이오 클로미프라민 함유 맛 차폐된 구강 투여용 약학 제제
MX394356B (es) 2016-01-20 2025-03-24 Theravida Inc Métodos y composiciones para tratar hiperhidrosis.
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe
JP2020105173A (ja) * 2018-12-27 2020-07-09 日本ケミファ株式会社 ２種以上の薬物を含有する口腔内崩壊錠及びその製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
JPS62126122A (ja) 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
SE457326B (sv) 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
JPH0780754B2 (ja) 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US5358717A (en) * 1989-12-22 1994-10-25 Syntex (U.S.A.) Inc. Directly-compressible naproxen or naproxen sodium compositions
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
TW271400B (pl) * 1992-07-30 1996-03-01 Pfizer
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
AUPO637197A0 (en) 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DE69721559T2 (de) * 1997-01-06 2003-11-27 Pfizer Inc., New York Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida
FR2785539B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration

Also Published As

Publication number Publication date
HK1049119A1 (en) 2003-05-02
ATE360412T1 (de) 2007-05-15
CZ300154B6 (cs) 2009-02-25
KR20020015062A (ko) 2002-02-27
IL147212A (en) 2007-05-15
ES2284507T3 (es) 2007-11-16
SK287322B6 (sk) 2010-07-07
EP1194125B1 (fr) 2007-04-25
WO2001003672A1 (fr) 2001-01-18
MA25426A1 (fr) 2002-04-01
HUP0202062A3 (en) 2004-05-28
US20020098227A1 (en) 2002-07-25
BR0012250A (pt) 2002-03-26
EA200200136A1 (ru) 2002-06-27
NO20016308D0 (no) 2001-12-21
AU5993600A (en) 2001-01-30
DK1194125T3 (da) 2007-07-30
KR100767928B1 (ko) 2007-10-17
CN1220485C (zh) 2005-09-28
CY1107695T1 (el) 2013-04-18
PT1194125E (pt) 2007-07-03
HU229568B1 (hu) 2014-02-28
DZ3257A1 (fr) 2001-01-18
EA003161B1 (ru) 2003-02-27
CA2375600C (fr) 2011-05-10
DE60034565T2 (de) 2007-12-27
JP4749639B2 (ja) 2011-08-17
DE60034565D1 (de) 2007-06-06
IL147212A0 (en) 2002-08-14
TR200200013T2 (tr) 2002-06-21
ZA200200344B (en) 2003-03-26
HK1049119B (zh) 2006-05-12
NO20016308L (no) 2001-12-21
US6660382B2 (en) 2003-12-09
BG106398A (en) 2002-09-30
CN1373658A (zh) 2002-10-09
PL201782B1 (pl) 2009-05-29
CA2375600A1 (fr) 2001-01-18
HUP0202062A2 (hu) 2002-12-28
SK19392001A3 (sk) 2002-04-04
CZ200218A3 (cs) 2002-04-17
NO331256B1 (no) 2011-11-07
MXPA01013354A (es) 2002-07-09
FR2795962B1 (fr) 2003-05-09
JP2003504324A (ja) 2003-02-04
NZ516594A (en) 2003-11-28
AU760006B2 (en) 2003-05-08
EP1194125A1 (fr) 2002-04-10
FR2795962A1 (fr) 2001-01-12
BG65615B1 (bg) 2009-03-31

Similar Documents

Publication Publication Date Title
PL354257A1 (pl) Sposób otrzymywania powlekanych granul o ukrytym sSposób otrzymywania powlekanych granul o ukrytym smaku, niezwłocznie uwalniających aktywny czynnikmaku, niezwłocznie uwalniających aktywny czynnik
EP1000615A3 (en) Preparation of pharmaceutically active particles
WO2002043702A3 (en) Pharmaceutical compositions for inhalation
IL147499A0 (en) Pharmaceutical composition containing fenofibrate and preparation method
BG103356A (en) Fungicide and polymer coated core-containing pellets
PL328021A1 (en) Granular mixture consisting of coated and uncoated fertiliser granules
DE69902177D1 (de) Nichtklumpende superabsorbierende polymere
AU3698100A (en) Nanocapsules containing charged particles, their uses and methods of forming thesame
WO2001051026A3 (en) Instant granules and process for their formulation
AU4671396A (en) Waste water treatment, media therefor and its manufacture
SE9701278L (sv) Pulverformigt biogent, av förbenade hjort framställt preparat och på det biogena preparatet baserad livsmedelstillsats
WO2000024877A3 (en) Matrix granule
WO1999021586A3 (en) Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
ES2174457T3 (es) Produccion de granulados detergentes.
WO1998051748A1 (en) Granulated powdery paint and process for producing the same
EP1469031A3 (en) Granulation of nonionic cellulose ether
AU8770301A (en) Process for the preparation of granules of methionine
AU4550497A (en) Process for the removal of dissolved metals and/or metalloids from an aqueous medium containing same and having a high content of salt
CA2273849A1 (en) Process for the production of a detergent composition
MXPA04003892A (es) Proceso para produccion de granulos de detergente.
WO1998056359A3 (de) Zusammensetzungen, die die wirkstofffreisetzung verzögern
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
JPS6326316A (ja) 焼結用微粉鉱石の造粒方法
AU3603595A (en) Granular bulk material, process for its production and its use
MY133364A (en) Process for preparing granular detergent compositions.